The prediagnostic period of Behçet’s disease: a nationwide population-based study
4 affiliations
- 1Rheumatology Unit, Galilee Medical Center
- 2The Azrieli Faculty of Medicine, Bar-Ilan University
- 3Leumit Research Institute, Leumit Health Services
- 4Department of Epidemiology and Preventive Medicine, School of Public Health, Grey Faculty of Medical and Health Sciences, Tel Aviv University
Abstract
Introduction: The diagnosis of Behçet’s disease (BD) is often delayed because its characteristic manifestations may emerge sequentially over time. Whether BD is preceded by a clinically active prediagnostic phase remains unclear. We aimed to characterize the clinical and laboratory features during the five-year period preceding the formal diagnosis of BD.
Methods: We conducted a nationwide retrospective matched case–control study using the electronic health records of Leumit Health Services. Patients with BD fulfilling the International Criteria for Behçet’s Disease or International Study Group classification criteria were identified by manual chart review and matched 1:5 with controls by sex, age, socioeconomic category and year of first observation. Clinical diagnoses, diagnostic investigations and laboratory measurements and medication dispensing recorded during the five years preceding diagnosis were compared between groups. Early and late laboratory measurements within the prediagnostic period were analyzed to assess temporal trends. Manifestations documented over the entire available record were analyzed separately.
Results: The study included 218 patients who subsequently developed BD and 1,090 matched controls. During the five years preceding diagnosis, future patients with BD more frequently exhibited oral aphthosis (36.2% vs 3.0%; OR 18.2), panuveitis (4.6% vs 0.1%; OR 52.4), inflammatory polyarthritis (7.3% vs 0.6%; OR 14.3), and venous thromboembolism (4.6% vs 0.2%; OR 26.2) (all P<0.001). Over the entire available record, oral aphthosis was documented in 61.0% of patients with BD and 11.8% of controls. Autoimmune serology was frequently requested but remained largely negative. Laboratory analyses demonstrated a biphasic trajectory. Absolute monocyte count and the neutrophil-to-lymphocyte ratio were lower than in controls at the early assessment (0.40 vs 0.44 ×10 ⁹ /L, P = 0.009, and 1.45 vs 1.49, P = 0.023) but significantly higher near diagnosis (0.64 vs 0.58 ×10 ⁹ /L, P = 0.025, and 2.44 vs 2.09, P = 0.003). This transition was accompanied by rising CRP, ESR, platelet count and globulin levels, persistently lower mean corpuscular volume and consistently higher IgA at both assessments (247 vs 189 mg/dL, P = 0.009, and 256 vs 189 mg/dL, P = 0.012), whereas IgG and IgM remained comparable between groups.
Conclusions: BD seems to be preceded by a clinically and biologically active prediagnostic phase characterized by a distinct inflammatory multisystem footprint.
Related
- Parenchymal Neuro-Behçet disease with heterogeneous clinical presentations: a comparative case report
- Epstein–Barr virus shapes intrathecal Th1/Th17 immunity and parenchymal involvement in neuro-Behçet’s disease
- CONSTANCES, the French nationwide population cohort: major accomplishments
- Uveitis in Patients with Inflammatory Bowel Disease: Pharmacovigilance Signal Detection and Nationwide Claims-Based Evaluation
- Clinical and economic burden of major lower-limb amputations attributable to peripheral artery disease in Italy: A nationwide analysis
BibTeX
@article{hassan2026prediagnostic,
title = {{The prediagnostic period of Behçet’s disease: a nationwide population-based study}},
author = {Fadi Hassan and Jawad Abu-Elhija and Areej Bayatra and Yolanda Friedrich and Mohammad E. Naffaa and Ariel Israel},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1970448},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1970448/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The prediagnostic period of Behçet’s disease: a nationwide population-based study
AU - Fadi Hassan
AU - Jawad Abu-Elhija
AU - Areej Bayatra
AU - Yolanda Friedrich
AU - Mohammad E. Naffaa
AU - Ariel Israel
PY - 2026
DA - 2026/10/14
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1970448
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1970448/full
AB - Introduction: The diagnosis of Behçet’s disease (BD) is often delayed because its characteristic manifestations may emerge sequentially over time. Whether BD is preceded by a clinically active prediagnostic phase remains unclear. We aimed to characterize the clinical and laboratory features during the five-year period preceding the formal diagnosis of BD. Methods: We conducted a nationwide retrospective matched case–control study using the electronic health records of Leumit Health Services. Patients with BD fulfilling the International Criteria for Behçet’s Disease or International Study Group classification criteria were identified by manual chart review and matched 1:5 with controls by sex, age, socioeconomic category and year of first observation. Clinical diagnoses, diagnostic investigations and laboratory measurements and medication dispensing recorded during the five years preceding diagnosis were compared between groups. Early and late laboratory measurements within the prediagnostic period were analyzed to assess temporal trends. Manifestations documented over the entire available record were analyzed separately. Results: The study included 218 patients who subsequently developed BD and 1,090 matched controls. During the five years preceding diagnosis, future patients with BD more frequently exhibited oral aphthosis (36.2% vs 3.0%; OR 18.2), panuveitis (4.6% vs 0.1%; OR 52.4), inflammatory polyarthritis (7.3% vs 0.6%; OR 14.3), and venous thromboembolism (4.6% vs 0.2%; OR 26.2) (all P<0.001). Over the entire available record, oral aphthosis was documented in 61.0% of patients with BD and 11.8% of controls. Autoimmune serology was frequently requested but remained largely negative. Laboratory analyses demonstrated a biphasic trajectory. Absolute monocyte count and the neutrophil-to-lymphocyte ratio were lower than in controls at the early assessment (0.40 vs 0.44 ×10 ⁹ /L, P = 0.009, and 1.45 vs 1.49, P = 0.023) but significantly higher near diagnosis (0.64 vs 0.58 ×10 ⁹ /L, P = 0.025, and 2.44 vs 2.09, P = 0.003). This transition was accompanied by rising CRP, ESR, platelet count and globulin levels, persistently lower mean corpuscular volume and consistently higher IgA at both assessments (247 vs 189 mg/dL, P = 0.009, and 256 vs 189 mg/dL, P = 0.012), whereas IgG and IgM remained comparable between groups. Conclusions: BD seems to be preceded by a clinically and biologically active prediagnostic phase characterized by a distinct inflammatory multisystem footprint.
SN - 1664-3224
ER -